Get the App
A

Aurinia (AUPH)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Aurinia (AUPH)

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in pa... Read more

  • USD10.20
  • USD11.04
  • USD10.01
  • USD13.42
  • 25.90%
  • 175M
  • 4.60M
  • 3.28M
  • 1.5B
  • 4.07
  • -19.50%

Stock News

Inside Foot Locker CEO's plan to run a better business

36 minutes ago

Inside Foot Locker CEO's plan to run a better business

Yahoo

Allegion to Host 2023 ‘Investor & Analyst Day’

1 hour ago

Allegion to Host 2023 ‘Investor & Analyst Day’

Yahoo

Virgin Orbit extends unpaid pause as Brown deal collapses, 'dynamic' talks continue

1 hour ago

Virgin Orbit extends unpaid pause as Brown deal collapses, 'dynamic' talks continue

CNBC

Top Stocks for April 2023

1 hour ago

Top Stocks for April 2023

Yahoo

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium